Figure 3.
Computerized tomography (CT) scans showing tumor regression in the right upper lobe lesion and the right hilar lesion following treatment with osimeritinib in an extensive-stage SCLC patient harboring EGFR L858R and T790M mutations.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.